Nov. 28, 2016 – Although President-elect Donald Trump was not who the Coalition for Healthcare Communication was preparing for in 2017, the organization will stay true to its mission of promoting and protecting the free flow of healthcare information under the Trump administration, according to Coalition Executive Director John Kamp, who spoke at the recent […]
Read moreSept. 10, 2015 – On the heels of last month’s ruling in Amarin v. FDA, which held that the FDA cannot prohibit companies from communicating truthful and non-misleading speech about the off-label uses of their products, a second lawsuit calling the FDA’s marketing enforcement practices into question has been filed in the U.S. District Court […]
Read moreNov. 22, 2011 – Stating that “a robust dialogue” between pharmaceutical companies and the public “would be seriously chilled” if the U.S. Court of Appeals for the Ninth Circuit upholds the 2009 criminal conviction of former InterMune CEO W. Scott Harkonen for allegedly making false statements about Actimmune in a press release, the Pharmaceutical Research […]
Read moreOct. 18, 2011 – A case filed by Par Pharmaceutical, Inc. against the FDA seeks to preserve Par”s First Amendment right to provide truthful information to physicians and other healthcare providers about the off-label use of Par”s prescription drug, Megace® ES, which is approved for the treatment of anorexia, cachexia, or an unexplained significant weight […]
Read moreJune 23, 2011 — Justices find Vermont violated First Amendment rights of pharma and data publishers Sweeping aside justifications by the state of Vermont and privacy advocates, the United States Supreme Court today found the Vermont ban on marketing use of Rx data a violation of the First Amendment. ” This is a victory for patients as […]
Read moreApril 5, 2011 – The Coalition for Healthcare Communication joined patient groups, two former Secretaries of the Department of Health and Human Services, the U.S. Chamber of Commerce and more than 50 organizations and individuals to file one of 16 amicus curiae briefs with the U.S. Supreme Court urging nullification of the Vermont prescription data […]
Read moreMarch 31, 2011 — At a time when interaction between biopharmaceutical companies and physicians is under increased scrutiny, a recent physician survey indicates that a majority of physicians find information provided by pharmaceutical and biotech research companies and their representatives to be a valuable resource, with 94 percent of physicians reporting that information from company […]
Read moreFeb. 18, 2011 — Although marketers are pushing for the acceptance of voluntary programs that allow consumers to opt out of Internet tracking for marketing purposes, two bills were introduced in Congress last week that would provide the Federal Trade Commission (FTC) with the authority to both define and regulate online tracking. On Feb. 10, […]
Read more
Jan. 31, 2011 – The Coalition for Healthcare Communication (CHC) today signed on with other leading marketing organizations to the Direct Marketing Association’s joint industry comments regarding the U.S. Department of Commerce’s Internet Policy Task Force’s green paper, entitled Commercial Data Privacy and Innovation in the Internet Economy: A Dynamic Policy Framework. work from home […]
Read more
Although 2011 brings political party shifts in Congress and new challenges, the mission of the Coalition for Healthcare Communication (CHC) remains the same: To protect, for society and individual patients, the benefit of the free flow of healthcare information. This year the CHC will be focusing on four major issues: (1) tax treatment of marketing […]
Read more